'Sinovac Vaccine Probably Won't Arrive Next Month'

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1566925_1_20201224181337.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm', 'DCS.dcsqry', '' ); } } }); }); });

2020-12-24 HKT 11:42

Share this story

facebook

  • David Hui says the Sinovac vaccine probably won't reach Hong Kong next month as expected. File photo: RTHK

    David Hui says the Sinovac vaccine probably won't reach Hong Kong next month as expected. File photo: RTHK

A government adviser on the pandemic said on Thursday that there will likely be a month's delay for Sinovac's vaccine to reach Hong Kong, as reports said the release of the jab's latest trial results in Brazil is being pushed back.

The mainland vaccine manufacturer was originally expected to publish its vaccine's phase three efficacy data around Wednesday, but it has now asked for the release to be put back by up to 15 days so that it can analyse the data from Brazil alongside that collected in Indonesia and Turkey.

Brazilian researchers said on Wednesday that preliminary data suggests Sinovac jabs are "more than 50 percent effective".

Health Secretary Sophia Chan had previously expected Hong Kong to get hold of the vaccine in January and have people injected by February or March.

But Chinese University's Professor David Hui said on a radio programme that the jabs will probably arrive only in February, adding that the BioNTech/Fosun Pharma vaccine may be the first available in the city.

Meanwhile, University of Hong Kong microbiologist Ho Pak-leung played down concerns over Sinovac’s delay in announcing the latest clinical data.

“For mainland vaccines, relevant departments like the National Medical Products Administration have tight supervision over the production and other areas,” he told an RTHK programme.

He added that the technology used by Sinovac to make the vaccine is mature.

But he urged the government to keep pushing for more information on the vaccine's efficacy on mutated coronavirus strains. (Additional reporting by Reuters)

RECENT NEWS

Ant Internationals Ant Bank And Bettr Selected For Hong Kongs GenAI Sandbox++

Digital bank Ant Bank and embedded financial solutions provider Bettr have been selected to participate in Hong Kong’... Read more

Visa And BOCHK Tapped For Hong Kong AI Sandbox To Test Agent-Initiated Commerce

Visa has announced that it is partnering with Bank of China (Hong Kong) (BOCHK) in the GenA.I. Sandbox++. With the Visa... Read more

Hong Kong Regulators Pick 36 Agentic AI Use Cases For GenA.I. Sandbox++

The Hong Kong Monetary Authority (HKMA), the Securities and Futures Commission (SFC), the Insurance Authority (IA), and... Read more

Finloop And Yunfeng Financial Become Latest Anchorpoint Authorised Distributors

Finloop and Yunfeng Financial have joined Anchorpoint’s HKDAP stablecoin beta access programme as authorised distribu... Read more

Standard Chartered Becomes First Bank To Distribute HKDAP Stablecoin

Standard Chartered Bank (Hong Kong) Limited (SCBHK) has become the first bank distributor of HKDAP, the Hong Kong dolla... Read more

Lianlian DigiTech Profit Doubles In H12026, Agent Wallet Pushes To Address Payment Needs

Lianlian DigiTech Co., Ltd, a payment service provider headquartered in China, reported its interim results for the fir... Read more